Introduction
Hidradenitis suppurativa is a chronic inflammatory disease of the skin that primarily affects hair follicles in areas where skin rubs together, such as the armpits, groin, buttocks, and under the breasts. It develops when the normal structure and function of the follicle unit break down, leading to follicular blockage, rupture, inflammation, and repeated tissue injury. Although the condition is often described by its visible lesions, its core biology involves a disorder of the follicle, the surrounding skin barrier, and the local immune response.
The disease is not simply an infection and not merely a surface skin irritation. It reflects a deeper physiological process in which the follicular opening becomes obstructed, the follicle enlarges and ruptures, and the contents of the follicle trigger an intense inflammatory reaction in the surrounding dermis. Over time, this can produce chronic tunnels, scarring, and repeated episodes of inflammation in the same regions.
The Body Structures or Systems Involved
Hidradenitis suppurativa mainly involves the pilosebaceous unit, the small skin structure made up of a hair follicle, the attached oil gland, and the follicular canal that opens onto the skin surface. This unit is distributed throughout the body, but the disease tends to appear in areas with many apocrine-associated regions and frequent friction, including the axillae, inguinal folds, perineum, and inframammary skin.
In healthy skin, the follicle produces a hair shaft and channels sebum and cellular material to the surface in an orderly way. The follicular opening remains patent, keratinocytes shed normally, and the surrounding immune environment stays balanced. The skin barrier also protects against mechanical irritation, microbes, and loss of fluid.
The condition also involves the innate and adaptive immune systems. Immune cells in the skin, including neutrophils, macrophages, and T cells, respond to follicular injury and tissue contents that escape into the dermis. The inflammatory signaling networks that regulate cytokines such as tumor necrosis factor alpha, interleukin-1, interleukin-17, and interleukin-23 are frequently active in the disease process. These pathways do not merely react to damage; they help drive and maintain the inflammatory state.
Mechanical factors matter as well. Skin folds create friction, humidity, and occlusion, all of which influence the local environment around the follicle. These physical conditions can promote blockage and increase the likelihood that damaged follicles will rupture.
How the Condition Develops
The earliest event in hidradenitis suppurativa is usually follicular occlusion. Cells lining the follicular canal proliferate and shed abnormally, producing a plug of keratin that narrows or blocks the opening. This obstruction traps follicular contents inside the structure. As pressure builds, the follicle enlarges and the wall becomes fragile.
When the follicular wall ruptures, its contents spill into the surrounding dermis. Keratin, bacteria that normally live on the skin, sebum, and other follicular debris are then recognized by the immune system as inflammatory signals. The body responds as if it has encountered injury and foreign material. This produces a strong local inflammatory reaction rather than a simple blocked pore.
The rupture sets off a cascade of immune activation. Neutrophils are recruited first, followed by other inflammatory cells that release cytokines and enzymes. These mediators increase swelling, tissue breakdown, and pain sensitivity in the affected area. The local inflammatory environment can persist because the same anatomic region remains prone to repeated blockage and rupture.
As the disease becomes chronic, repeated episodes of inflammation alter the architecture of the skin. The body attempts to repair the damage by laying down collagen and forming scar tissue. Instead of returning fully to normal, the area may develop interconnected tracts beneath the surface, often called sinus tracts or tunnels. These form when recurring inflammation creates abnormal channels between damaged follicles, abscess cavities, and the skin surface.
This process explains why hidradenitis suppurativa tends to recur in the same sites. The disease is self-reinforcing: follicular obstruction causes rupture, rupture causes inflammation, inflammation causes tissue remodeling and scarring, and scarring can further distort the follicular architecture and local drainage.
Structural or Functional Changes Caused by the Condition
One of the main structural changes is follicular dilation followed by rupture. The follicle becomes stretched and unstable, and the normal channel for shedding material is lost. This creates a closed space where debris accumulates and pressure rises.
Another major change is persistent inflammation within the dermis and subcutaneous tissue. Inflammation increases blood flow, recruits immune cells, and raises local concentrations of chemical mediators. These changes make the skin tender, warm, and swollen, but more importantly they alter tissue function at a microscopic level. Collagen is broken down and rebuilt repeatedly, which gradually distorts the skin structure.
As the condition advances, fibrosis becomes prominent. Fibrosis is the formation of dense scar tissue after repeated injury. In hidradenitis suppurativa, fibrosis can thicken the skin, restrict normal elasticity, and create firm bands beneath the surface. This scarring changes how the skin moves and may interfere with drainage from nearby follicles.
The formation of sinus tracts is a defining functional consequence of chronic disease. These are abnormal channels lined by inflamed tissue that can connect deeper abscesses to the surface or connect one damaged area to another. They prevent complete healing because inflammatory material can continue to move through them, and they provide a structural route for recurrence.
At the functional level, the skin in affected areas loses its normal resilience. Instead of serving as a flexible barrier, the tissue becomes a site of repeated inflammation, breakdown, and repair. The result is a shift from normal follicular physiology to a chronic wound-like state.
Factors That Influence the Development of the Condition
Genetic susceptibility plays a significant role. Some people inherit tendencies that affect follicular keratinization, inflammatory signaling, or tissue repair. In a minority of cases, mutations affecting components of the gamma-secretase complex have been identified, suggesting that altered follicle development and cell signaling can contribute to disease. Even when no single mutation is found, family history is common, which indicates that multiple genes may influence risk.
Hormonal regulation also appears to affect disease expression. The condition often begins after puberty, when androgen-sensitive skin structures become more active and changes in sebum production, follicular keratinization, and body hair distribution occur. This timing suggests that hormonal milieu helps shape the follicular environment, although hormones are not the sole cause.
Immune dysregulation is central to the disease. People with hidradenitis suppurativa show increased activity in inflammatory pathways that amplify the skin response to follicular rupture. Rather than resolving after the initial injury, the immune reaction remains prolonged and can become exaggerated. This makes the tissue more likely to cycle through inflammation and repair.
Environmental and mechanical influences matter because they affect the follicular microenvironment. Friction, moisture, and occlusion in skin folds can raise the likelihood of blockage and irritation. These conditions do not create the disease on their own, but they can intensify the biological processes that lead to follicular rupture.
The skin microbiome may also influence inflammation. Hidradenitis suppurativa is not caused by a single infectious agent, but bacterial communities in affected skin can interact with immune cells and damaged follicles. Once the follicle has ruptured, these microbes may contribute to persistence of inflammation even when they are not the original trigger.
Variations or Forms of the Condition
Hidradenitis suppurativa exists on a spectrum. In milder disease, inflammation may remain limited to intermittent nodules or small abscesses in one or a few areas. The follicular inflammation is present, but tissue destruction and tunnel formation are minimal. These cases reflect a more localized inflammatory response without extensive structural remodeling.
In more advanced forms, the disease becomes widespread within a region and includes multiple interconnected tracts, recurrent abscesses, and extensive scarring. Here the underlying biology has shifted from episodic follicular rupture to chronic architectural distortion of the skin. The affected area may contain both active inflammatory lesions and older scarred tissue, showing that the process is ongoing rather than isolated.
The disease can also differ by pattern of involvement. Some people have lesions confined to one anatomic region, while others develop inflammation in several intertriginous sites. This variation likely reflects differences in local friction, follicular density, genetic predisposition, and immune responsiveness.
From a pathological standpoint, the same core mechanism underlies all forms, but the balance between inflammation, repair, and scarring determines how the disease appears. When inflammation is brief and limited, the changes may remain superficial. When the process repeats frequently, the tissue undergoes deeper remodeling and more permanent structural damage.
How the Condition Affects the Body Over Time
Over time, hidradenitis suppurativa can shift from a disorder of recurrent follicular obstruction to a chronic inflammatory condition with permanent tissue change. Repeated injury drives ongoing immune activation, and each cycle of rupture and repair increases the amount of scar tissue in the affected skin. This makes the local anatomy less stable and more prone to future episodes.
Long-standing disease can produce thickened, fibrotic plaques and interconnected tunnels that alter the normal architecture of the skin and subcutaneous tissue. These structural changes can interfere with movement in areas such as the axilla or groin because the skin loses elasticity and becomes tethered by scar tissue.
Chronic inflammation also affects local drainage and tissue oxygenation. Swelling and scarring can compress small vessels and impair normal circulation in the region, which may slow healing and perpetuate a cycle of breakdown and repair. The tissue may behave more like a chronically inflamed wound than healthy skin.
In severe cases, long-term disease can lead to secondary complications from repeated tissue injury, such as extensive scarring, persistent sinus tracts, and altered anatomy of the affected areas. The chronic inflammatory burden may also influence the body’s broader inflammatory state, although the main damage remains concentrated in the skin and adjacent soft tissue.
The persistence of the condition reflects the fact that its driving mechanisms remain active: follicular occlusion, rupture, immune activation, and tissue remodeling continue to reinforce one another unless the process is interrupted. This is why the disease often behaves as a long-term structural and inflammatory disorder rather than a short-lived skin eruption.
Conclusion
Hidradenitis suppurativa is a chronic inflammatory disease centered on the hair follicle and surrounding skin in friction-prone body folds. Its defining biological features are follicular blockage, rupture of the follicle wall, activation of the local immune system, and progressive tissue remodeling that can lead to scarring and sinus tract formation.
Understanding the condition requires looking beyond surface lesions to the mechanisms underneath them. Normal follicular function is disrupted, immune signaling becomes prolonged and amplified, and repeated injury changes the structure of the skin itself. These processes explain why the disease can persist, recur in the same locations, and gradually reshape the affected tissue over time.